Bowel (colorectal) cancer, Secondary cancers
Open
Phase 2/3
This trial is comparing pumitamig and chemotherapy with bevacizumab and chemotherapy for advanced bowel cancer.
It is open to people with bowel cancer that has spread to another part of the body or has come back. Also:
they have not had treatment yet and
their cancer cannot be removed with surgery
You pronounce pumitamig as puh-mih-tah-mig.
Recruitment start: 10 February 2026
Recruitment end: 28 June 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Naureen Starling
Bristol-Myers Squibb
BioNTech
Last reviewed: 05 Nov 2026
CRUK internal database number: 20216
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
